Makers of dietary supplements are actively lobbying the Food and Drug Administration (FDA) to expand the range of ingredients permitted in their products. This push could pave the way for increased marketing of popular wellness items like peptides and probiotics, which currently face regulatory hurdles.
Key Takeaways
- The FDA is reviewing its criteria for dietary supplements, considering the inclusion of substances not traditionally found in food.
- Industry groups cite regulatory uncertainty and cost as reasons for seeking broader ingredient definitions.
- Consumer advocates express concern over potential market expansion and the FDA’s ability to oversee new substances.
Expanding the Definition of Dietary Ingredients
The FDA recently held a public meeting to discuss its long-standing criteria for dietary supplements. The core issue revolves around whether the definition of a "dietary ingredient" can be broadened to encompass substances that do not originate from food, vitamins, herbs, or other conventional sources. This meeting, the first of its kind since Robert F. Kennedy Jr. took a prominent health role, was requested by the Natural Products Association, an industry group that has frequently disagreed with the FDA on new supplement ingredients.
Kyle Diamantas, the FDA’s top food official, acknowledged the industry’s significant growth over the past three decades, noting that the regulatory framework has remained largely unchanged. He expressed a commitment to "cutting red tape" to reduce industry costs and uncertainties arising from unclear regulatory expectations.
The Challenge of New Wellness Products
Under current FDA regulations, dietary supplements are classified as a category of food, with most ingredients derived from plants, herbs, and substances found in the typical American diet. This definition poses a challenge for the industry as newer wellness products often incorporate ingredients that have never been part of the food supply.
Peptides, for example, are amino acid chains that have gained popularity through celebrity endorsements for muscle building and anti-aging benefits, despite limited scientific backing. While often sold by specialty pharmacies as injections or IV infusions, some supplement manufacturers are now adding them to capsules, gummies, and powders. According to FDA lawyers, these products technically contravene existing rules, as do certain probiotics marketed for digestive and gut health.
Industry representatives argue that the current law does not explicitly mandate that all ingredients must originate from food. They hope the FDA will adopt a more expansive interpretation of "dietary ingredient" to include substances not already present in food.
Concerns from Consumer Advocates
Conversely, consumer advocates warn that allowing a wider array of ingredients could significantly expand the supplement market, which they believe the FDA already struggles to effectively oversee. Jensen Jose of the Center for Science in the Public Interest stated at the meeting that the FDA should prioritize enhancing the safety of the current market rather than introducing more chemicals and substances into supplements.
Industry Allies and Regulatory Oversight
Robert F. Kennedy Jr. has expressed support for peptides, even claiming personal use for injury treatment and vowing to ease restrictions on injectable peptides. Some of his associates and supporters are also involved in the wellness industry, including individuals who sell peptide-based products. Furthermore, former health advisors from Kennedy’s presidential campaign have ties to the supplement industry, with one co-founding a platform for health spending on wellness goods and another having earned substantial income promoting supplements.
The FDA’s oversight of dietary supplements is notably less stringent than that for drugs. The agency does not pre-approve supplements for safety or effectiveness, nor does it maintain a comprehensive list of all products on the market. Manufacturers are legally responsible for ensuring their products are safe and accurately advertised, and they are prohibited from claiming to treat specific diseases. The 1994 law governing supplements also exempted manufacturers from certain nutrition labeling requirements, allowing them to make broader claims about supporting health and well-being, often accompanied by a disclaimer that the statements have not been evaluated by the FDA.
